Antivirals on the agenda
Federal and state health ministers to discuss increasing awareness of anti-viral COVID treatments, Mark Butler says The federal health minister has again flagged the need for an information campaign to …
Biosimilars: still a work in progress
Evidence is pointing to most pharmacists still struggling to come to grips with their role in providing biosimilar medicines It’s now been seven years since the Pharmaceutical Benefits Advisory Committee …
Pharmacy trials again under fire
“An absurd and dangerous watering down of patient and primary care”: AMA returns the heat on prescribing and UTI trials, but Guild says it’s all lies Another war of words …
Flu vax extensions spreading
More states fall into line and extend free influenza vaccination programs amid concerns over slow uptake New South Wales, Queensland and South Australia have followed Victoria’s recent announcement and also …
A new era for naloxone
Free naloxone program kicks off, welcomed by pharmacists The national rollout of the Take Home Naloxone (THN) program, which allows pharmacists to provide free naloxone, kicks off from today (1 …
A suburban ‘doctor desert’
Report reveals the travel times to access doctors in the outer suburbs of Australia’s cities The average distance to the nearest doctor is more than 9km in some outer metropolitan …
World News Wrapup: 30 June 2022
Walgreens takes Boots off the market; the pharmaceutical impact of the US Supreme Court overturning Roe v Wade: Pharmacy to boost cheaper cannabis sales US: Pharmacy giant Walgreens has dropped …
TGA reports on Covid vax numbers, fatalities
Here’s some of the key statistics and findings from the TGA’s latest COVID-19 vaccine safety report, including reports of myocarditis, pericarditis and rare fatalities The Therapeutic Goods Administration confirms 13 …
Pharmacist prescribing by 2023?
Community pharmacy has seen its role enhanced during the pandemic, so what does it need to do to further this? PSA has outlined some key steps Prescribing of Schedule 4 …
What does an RMMR achieve?
RMMR provision reduced some medicines, but not others, after a year in an aged care facility, study finds A large population-based examination of medicines use in Australian residential aged care …
Fines for RATs
TGA fines manufacturer for multiple regulatory infringements The Therapeutic Goods Administration (TGA) has issued eight infringement notices totalling $106,560 to a manufacturers, Hough Pharma, for allegedly failing to provide information …
Politicians offer support to expanded practice
Politicians from either side of the political and state/federal divides have honoured the role of community pharmacy and acknowledged the need for increased scope of practice Speaking at a Pharmacy …